Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Path Holdings (NQ: BPTH )

4.200 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.200
Bid (Size) 5.040 (25)
Ask (Size) 5.100 (19)
Prev. Close 4.200
Today's Range 4.200 - 4.200
52wk Range 0.3200 - 7.670
Shares Outstanding 678,795
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Bio-Path Holdings, Inc.
Via GlobeNewswire

Performance

YTD
+752.79%
+752.79%
1 Month
-7.89%
-7.89%
3 Month
+900.24%
+900.24%
6 Month
+726.45%
+726.45%
1 Year
+190.66%
+190.66%

More News

Read More
Why Bio-Path Stock Is Soaring
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Bio-Path Holdings's Earnings: A Preview
Via Benzinga
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Walgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Bio-Path Holdings Inc. (NASDAQ: BPTH) Near Top of Volume Charts in Thursday Trading
Via Investor Brand Network
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
Via InvestorPlace
Why Is Bio-Path (BPTH) Stock Up 89% Today?
Via InvestorPlace
Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Expands Global Patent Portfolio
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Provides 2024 Clinical and Operational Update
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23
Via Newsfile
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Bio-Path Holdings Shares Are Falling Today
Via Benzinga
Bio-Path Holdings Reports Full Year 2023 Financial Results
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For March 8, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
From Bio-Path Holdings, Inc.
Via GlobeNewswire
Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
From Bio-Path Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.